Names and pronunciation
(tra-me′ti-nib) MeKinist
PDF page 1321
Drug reference
(tra-me′ti-nib) MeKinist
PDF page 1321
Func. class.: Antineoplastic biologic response modifiers
PDF page 1321
Chem. class.: Signal transduction in- hibitors (STIs), tyrosine kinase inhibitor
PDF page 1321
USES: Unresectable or metastatic BRAD V600E or BRAF V600K mutated malignant melanoma, non-small cell lung cancer, thyroid cancer
PDF page 1322
CONTRAINDICATIONS: Preg- nancy, hypersensitivity
PDF page 1322
DOSAGE AND ROUTES Unresectable or metastatic malignant melanoma • Adult: PO 2 mg daily; may be used in combination with dacarbazine or PACLi- taxel in those with BRAF V600E Unresectable or metastatic malignant melanoma • Adult: PO 2 mg daily with dabrafenib 150 mg q12hr until disease progression, take both at same time
PDF page 1322
Available forms: Tabs 0.5, 2 mg
PDF page 1322
• Adult: PO 2 mg daily; may be used in combination with dacarbazine or PACLi- taxel in those with BRAF V600E Unresectable or metastatic malignant melanoma
PDF page 1322
• Adult: PO 2 mg daily with dabrafenib 150 mg q12hr until disease progression, take both at same time
PDF page 1322